Study supports early use of antifungal therapy in NICU babies

04/6/2012 | Medscape (free registration)

Empiric antifungal therapy should be considered before blood culture results are available for extremely low birth weight babies at high risk of invasive Candida to help prevent death or neurodevelopmental impairment, researchers reported in The Journal of Pediatrics. Duke University researchers said Candida species are a leading cause of death in NICUs and waiting for blood culture results could take days and have fatal consequences.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA